Literature DB >> 18371448

Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Matthias Stadtfeld1, Nimet Maherali, David T Breault, Konrad Hochedlinger.   

Abstract

Ectopic expression of the transcription factors Oct4, Sox2, c-Myc, and Klf4 in fibroblasts generates induced pluripotent stem (iPS) cells. Little is known about the nature and sequence of molecular events accompanying nuclear reprogramming. Using doxycycline-inducible vectors, we have shown that exogenous factors are required for about 10 days, after which cells enter a self-sustaining pluripotent state. We have identified markers that define cell populations prior to and during this transition period. While downregulation of Thy1 and subsequent upregulation of SSEA-1 occur at early time points, reactivation of endogenous Oct4, Sox2, telomerase, and the silent X chromosome mark late events in the reprogramming process. Cell sorting with these markers allows for a significant enrichment of cells with the potential to become iPS cells. Our results suggest that factor-induced reprogramming is a gradual process with defined intermediate cell populations that contain the majority of cells poised to become iPS cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18371448      PMCID: PMC3538379          DOI: 10.1016/j.stem.2008.02.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  36 in total

1.  A PCR primer bank for quantitative gene expression analysis.

Authors:  Xiaowei Wang; Brian Seed
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

2.  SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult.

Authors:  Pam Ellis; B Matthew Fagan; Scott T Magness; Scott Hutton; Olena Taranova; Shigemi Hayashi; Andrew McMahon; Mahendra Rao; Larysa Pevny
Journal:  Dev Neurosci       Date:  2004 Mar-Aug       Impact factor: 2.984

3.  Non-invasive sexing of preimplantation stage mammalian embryos.

Authors:  A K Hadjantonakis; M Gertsenstein; M Ikawa; M Okabe; A Nagy
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

4.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Virus infection of murine teratocarcinoma stem cell lines.

Authors:  N M Teich; R A Weiss; G R Martin; D R Lowy
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

6.  Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells.

Authors:  E Barklis; R C Mulligan; R Jaenisch
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

7.  X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos.

Authors:  E J Robertson; M J Evans; M H Kaufman
Journal:  J Embryol Exp Morphol       Date:  1983-04

8.  Spatial distribution and initial changes of SSEA-1 and other cell adhesion-related molecules on mouse embryonic stem cells before and during differentiation.

Authors:  Li Cui; Kohei Johkura; Fengming Yue; Naoko Ogiwara; Yasumitsu Okouchi; Kazuhiko Asanuma; Katsunori Sasaki
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

9.  Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei.

Authors:  T Wakayama; A C Perry; M Zuccotti; K R Johnson; R Yanagimachi
Journal:  Nature       Date:  1998-07-23       Impact factor: 49.962

10.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.

Authors:  Alexander Meissner; Marius Wernig; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2007-08-27       Impact factor: 54.908

View more
  349 in total

Review 1.  Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Authors:  Kenneth R Boheler
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

Review 2.  The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.

Authors:  Eriona Hysolli; Yong Wook Jung; Yoshiaki Tanaka; Kun-Yong Kim; In-Hyun Park
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

4.  The labyrinth of nuclear reprogramming.

Authors:  Ignacio Sancho-Martinez; Emmanuel Nivet; Juan Carlos Izpisua Belmonte
Journal:  J Mol Cell Biol       Date:  2011-11-16       Impact factor: 6.216

5.  Characterization and fate of telomerase-expressing epithelia during kidney repair.

Authors:  Jie Song; Suzanne Czerniak; Teresa Wang; Wendy Ying; Diana L Carlone; David T Breault; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

6.  Two-factor reprogramming of somatic cells to pluripotent stem cells reveals partial functional redundancy of Sox2 and Klf4.

Authors:  A Nemajerova; S Y Kim; O Petrenko; U M Moll
Journal:  Cell Death Differ       Date:  2012-04-27       Impact factor: 15.828

7.  A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Authors:  Rebekah L Gundry; Daniel R Riordon; Yelena Tarasova; Sandra Chuppa; Subarna Bhattacharya; Ondrej Juhasz; Olena Wiedemeier; Samuel Milanovich; Fallon K Noto; Irina Tchernyshyov; Kimberly Raginski; Damaris Bausch-Fluck; Hyun-Jin Tae; Shannon Marshall; Stephen A Duncan; Bernd Wollscheid; Robert P Wersto; Sridhar Rao; Jennifer E Van Eyk; Kenneth R Boheler
Journal:  Mol Cell Proteomics       Date:  2012-04-06       Impact factor: 5.911

8.  Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature.

Authors:  Huansheng Xu; B Alexander Yi; Hao Wu; Christoph Bock; Hongcang Gu; Kathy O Lui; Joo-Hye C Park; Ying Shao; Alyssa K Riley; Ibrahim J Domian; Erding Hu; Robert Willette; John Lepore; Alexander Meissner; Zhong Wang; Kenneth R Chien
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

Review 9.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

Review 10.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.